Renal aspects of primary hyperparathyroidism

Patients and methods
Nephrolithiasis and bone disease are the most common complications of primary hyperparathyroidism (PHPT). The aim of this study was to evaluate the relationships between the existence of kidney stones, renal function and bone mineral density (BMD) in PHPT.
Biomedical evaluation, BMD measurements (DEXA, Lunar) and renal ultrasonography were performed in a group of 75 consecutive PHPT patients aged 57.6 ± 12.7 years.
Exclusion criteria were other diseases and medications known to interfere with bone or mineral metabolism or renal function.
The control group consisted of 47 generally healthy volunteers. 30 patients with PHPT were subsequently investigated again one year after effective parathyroidectomy (PTX).
Statistical analysis
The data were analyzed using Statistica 10 (StatSoft Inc.). The statistical significance of differences between paired data was calculated using Wilcoxon's signed rank test and the Mann-Whitney U test was used to compare values between different sample groups. Correlation coefficients were determined using Spearman's rank correlation. Statistical significance was defined as p<0.05. Laboratory methods Serum and urinary solutes and alkaline phosphatase (ALP) were measured using standard laboratory methods. Serum intact parathormone PTH was estimated with twosite immuno-chemiluminometric assay (Immulite 2000, DPC, Germany). Osteocalcin was estimated by IRMA using a kit (CISbio, France). The bone resorption marker ICTP (cross-linked carboxy terminal telopeptide of type I collagen) was estimated with an RIA kit (Orion Diagnostica). Osteoprotegerin was determined using a commercially available enzyme-linked immunosorbent assay (ELISA) (Biomedica Medizinprodukte GMBH, Vienna, Austria) 1,25-dihydroxy vitamin D and 25-hydroxy vitamin D plasma concentrations were measured using an RIA kit (DIASource ImmunoAssays S.A. Belgium). 
